Clinical Trials Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12 Jan 2021
FDA lifts partial clinical hold on Mersana’s Phase l study of XMT-1522 The US Food and Drug Administration (FDA) has lifted the partial clinical hold on a... 18th September 2018